Siemens Healthineers, DE000SHL1006

Flagship imaging push, Siemens Healthineers’ Naeotom Alpha sets the CT pace

15.06.2026 - 22:12:16 | ad-hoc-news.de

With photon-counting detectors, Siemens Healthineers’ Naeotom Alpha aims to redefine flagship CT imaging by delivering higher spatial resolution at lower dose, and is now being rolled out as a premium workhorse in high-volume radiology and cardiology centers.

Siemens Healthineers, DE000SHL1006
Siemens Healthineers, DE000SHL1006

Edited by ad hoc news Flagship & Bestseller Desk. Reviewed before publication on 06/15/2026 at 4:15 PM ET. Details in the imprint.

Photon-counting CT was long a research topic; with the Naeotom Alpha, Siemens Healthineers has turned it into a commercial flagship scanner that hospitals can actually buy and install. The premium system is marketed as the first FDA-cleared clinical photon-counting CT, targeting radiology and cardiology departments that need high spatial resolution imaging at significantly reduced radiation dose compared with conventional CT systems. According to Siemens Healthineers, Naeotom Alpha is designed as a high-throughput workhorse for advanced cardiac, oncology and lung imaging in leading medical centers. The official product page details the system’s photon-counting detector technology and clinical focus.

How Naeotom Alpha’s photon-counting CT technology works in practice

Naeotom Alpha replaces the energy-integrating detectors used in most conventional CT scanners with cadmium telluride photon-counting detectors that register individual X-ray photons and their energy. Instead of summing total energy, the detector architecture allows direct conversion of X-ray photons into electrical signals, which Siemens Healthineers says improves spatial resolution and contrast-to-noise ratio while reducing electronic noise. The company also highlights more efficient use of X-ray quanta, enabling high-quality images at lower radiation doses for patients compared with equivalent procedures on traditional CT platforms. These characteristics are aimed at challenging clinical situations such as imaging of small vessels, subtle lung disease or coronary plaque.

From an application standpoint, Naeotom Alpha is positioned for a broad spectrum of exams, but the cardiology use case is particularly prominent in Siemens Healthineers’ communication. The system’s high temporal resolution and energy-resolved data acquisition support coronary CT angiography with improved visualization of calcified and mixed plaques, while spectral information can be used to characterize materials such as iodine or calcium within a single scan. Siemens Healthineers markets this as a way to extract more diagnostic information from each exam, potentially reducing the need for additional follow-up imaging in some patients. High-speed gantry rotation and advanced reconstruction algorithms are designed to keep motion artifacts low, even at higher heart rates, which is a key demand of busy cardiac centers.

On the hardware side, Naeotom Alpha sits at the top end of the company’s CT portfolio as a large, fixed installation system geared toward tertiary care hospitals and specialized imaging centers. It features a multi-slice detector configuration with whole-organ coverage, integrated patient positioning aids and automation tools that aim to support high daily scan volumes. Siemens Healthineers emphasizes workflow support such as automated scan planning, standardized protocols and integration with its broader digital ecosystem to help sites maintain consistent imaging quality across technologists and shifts. For radiology administrators, the flagship positioning also means the scanner is expected to serve as a marketing instrument for attracting referrals in competitive urban markets.

The premium nature of the system is reflected in its target customer segment and likely pricing band, which is typical for top-tier CT scanners that command investment decisions at the hospital board level rather than departmental budgets. Public information points to Naeotom Alpha being installed at leading academic medical centers and large regional hospitals in Europe, North America and selected Asia-Pacific markets as early adopters. These sites often use the system for complex cardiac and oncologic imaging, evidence-generation studies and demonstration of cutting-edge capabilities to referring physicians and patients. As a result, Naeotom Alpha functions not only as a clinical tool but also as a flagship reference for Siemens Healthineers in many national markets.

Sustainability and serviceability aspects have also been woven into the Naeotom Alpha offering, in line with broader procurement criteria at major hospital groups. The company points to lifecycle service contracts, remote monitoring and software-driven upgrades as core elements of the system’s value proposition, allowing customers to keep imaging protocols and reconstruction options current over many years of use. This fits Siemens Healthineers’ strategy of tying capital equipment sales closely to long-term service and software revenue streams, with Naeotom Alpha providing a high-priced anchor at the top of the CT portfolio. Installations of photon-counting CT create a base for future clinical applications and software packages that can be rolled out as they gain regulatory clearances and reimbursement recognition.

For Siemens Healthineers overall, Naeotom Alpha is a flagship product that underscores the company’s ambition to differentiate in advanced imaging hardware rather than compete primarily on price in mid-range segments. The system is used in marketing and investor materials as an example of how the company aims to drive growth by commercializing next-generation detector technologies and integrating them with workflow and AI capabilities. External industry coverage has consistently cited Naeotom Alpha when discussing photon-counting CT as a key innovation trend in medical imaging. Specialized imaging trade press has analyzed early clinical experience with photon-counting CT systems including Naeotom Alpha.

Shares of Siemens Healthineers (DE000SHL1006) are traded on Xetra in euros; recent exchange data show the stock changing hands on the Frankfurt market as part of Germany’s DAX family of healthcare names. The Xetra listing provides up-to-date price and volume information for investors tracking the company’s performance.

Siemens Healthineers Naeotom Alpha in brief

  • Product: Naeotom Alpha photon-counting CT scanner
  • Manufacturer: Siemens Healthineers AG
  • Category: Flagship / premium CT imaging system
  • Launch date: Initial commercial launch after regulatory clearance in early 2020s (regional rollout timing varies)
  • MSRP / Price: High-end hospital capital equipment segment; specific list prices typically subject to tender and not publicly disclosed
  • Availability: Installed at leading hospitals and imaging centers in Europe, North America and selected Asia-Pacific markets
  • Target audience: Tertiary care hospitals, academic medical centers and high-volume radiology and cardiology departments
  • Key differentiator / USP: Clinical photon-counting CT with cadmium telluride detectors designed for higher resolution and lower dose compared with conventional CT systems

More on Siemens Healthineers in the markets

Investors and professionals who follow Siemens Healthineers can find further regulatory updates and financial information through dedicated channels.

More Siemens Healthineers coverage Investor Relations

Sentiment and discussion around Naeotom Alpha

YouTube X TikTok Instagram

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.

en | DE000SHL1006 | SIEMENS HEALTHINEERS | boerse | 69547547 | bgmi